| Reference |
|---|
Cao Z, Yang X, Yang W, Chen F, Jiang W, Zhan S, et al. Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes. ACS Nano. 2024;18:7618-7632 pubmed publisher |
Bhatta R, Han J, Liu Y, Bo Y, Lee D, Zhou J, et al. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nat Commun. 2023;14:8047 pubmed publisher |
Lin Y, Chen C, Ku Y, Wang L, Hung C, Lin Z, et al. A modified SELEX approach to identify DNA aptamers with binding specificity to the major histocompatibility complex presenting ovalbumin model antigen. RSC Adv. 2023;13:32681-32693 pubmed publisher |
Dan J, Cai J, Zhong Y, Wang C, Huang S, Zeng Y, et al. Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine. Cell Rep Med. 2023;4:101229 pubmed publisher |
Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. J Clin Invest. 2022;132: pubmed publisher |
Regev O, Kizner M, Roncato F, Dadiani M, Saini M, Castro Giner F, et al. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells. Front Immunol. 2022;13:849701 pubmed publisher |
Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365-378.e6 pubmed publisher |
Wang Z, Xu F, Hu J, Zhang H, Cui L, Lu W, et al. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity. J Immunother Cancer. 2021;9: pubmed publisher |
Kelly S, Cossette B, Varadhan A, Wu Y, Collier J. Titrating Polyarginine into Nanofibers Enhances Cyclic-Dinucleotide Adjuvanticity in Vitro and after Sublingual Immunization. ACS Biomater Sci Eng. 2021;7:1876-1888 pubmed publisher |
Van Hoecke L, Roose K, Ballegeer M, Zhong Z, Sanders N, De Koker S, et al. The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration. Mol Ther Nucleic Acids. 2020;22:373-381 pubmed publisher |
Ghosh S, Dellibovi Ragheb T, Kerviel A, Pak E, Qiu Q, Fisher M, et al. β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell. 2020;183:1520-1535.e14 pubmed publisher |
von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher |
Lin C, Ren W, Luo Y, Li S, Chang Y, Li L, et al. Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade. Cancer Immunol Res. 2020;8:632-647 pubmed publisher |
Wang Z, Chen J, Hu J, Zhang H, Xu F, He W, et al. cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity. J Clin Invest. 2019;129:4850-4862 pubmed publisher |
Ziegler P, Bollrath J, Pallangyo C, Matsutani T, Canli O, De Oliveira T, et al. Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis. Cell. 2018;174:88-101.e16 pubmed publisher |
Saunderson S, McLellan A. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes. J Immunol. 2017;199:2225-2235 pubmed publisher |
Lybaert L, Ryu K, De Rycke R, Chon A, De Wever O, Vermaelen K, et al. Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy. Adv Sci (Weinh). 2017;4:1700050 pubmed publisher |
Kuai R, Ochyl L, Bahjat K, Schwendeman A, Moon J. Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater. 2017;16:489-496 pubmed publisher |
Song C, Noh Y, Lim Y. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. Int J Nanomedicine. 2016;11:3753-64 pubmed publisher |
Ersching J, Basso A, Kalich V, Bortoluci K, Rodrigues M. A Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T Cells. PLoS Pathog. 2016;12:e1005698 pubmed publisher |
Wu C, Liu S, Chen H, Shen K, Leng C. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population. Oncotarget. 2016;7:30804-19 pubmed publisher |
Andersen B, Xia J, Epstein A, Ohlfest J, Chen W, Blazar B, et al. Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant. J Immunother Cancer. 2016;4:11 pubmed publisher |
Krummey S, Martinez R, Andargachew R, Liu D, Wagener M, Kohlmeier J, et al. Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity. J Immunol. 2016;196:2838-46 pubmed publisher |
Black L, Saunderson S, Coutinho F, Muhsin Sharafaldine M, Damani T, Dunn A, et al. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. Immunol Cell Biol. 2016;94:430-8 pubmed publisher |
Tähtinen S, Kaikkonen S, Merisalo Soikkeli M, Grönberg Vähä Koskela S, Kanerva A, Parviainen S, et al. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors. PLoS ONE. 2015;10:e0131242 pubmed publisher |
Tzelepis F, Verway M, Daoud J, Gillard J, Hassani Ardakani K, Dunn J, et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J Clin Invest. 2015;125:752-68 pubmed publisher |
Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher |
Jang B, Kim H, Kim J, Kim W, Lee B, Kim S, et al. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings. J Leukoc Biol. 2015;97:351-62 pubmed publisher |
Sreejit G, Ahmed A, Parveen N, Jha V, Valluri V, Ghosh S, et al. The ESAT-6 protein of Mycobacterium tuberculosis interacts with beta-2-microglobulin (β2M) affecting antigen presentation function of macrophage. PLoS Pathog. 2014;10:e1004446 pubmed publisher |
Shen K, Song Y, Chen I, Leng C, Chen H, Li H, et al. Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. J Immunol. 2014;192:4233-41 pubmed publisher |
Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher |
Imai T, Ishida H, Suzue K, Hirai M, Taniguchi T, Okada H, et al. CD8(+) T cell activation by murine erythroblasts infected with malaria parasites. Sci Rep. 2013;3:1572 pubmed publisher |
Moreau H, Lemaitre F, Terriac E, Azar G, Piel M, Lennon Dumenil A, et al. Dynamic in situ cytometry uncovers T cell receptor signaling during immunological synapses and kinapses in vivo. Immunity. 2012;37:351-63 pubmed publisher |
Woller N, Knocke S, Mundt B, Gürlevik E, Strüver N, Kloos A, et al. Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. J Clin Invest. 2011;121:2570-82 pubmed publisher |
Hahn S, Setz C, Wild J, Schubert U. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation. J Immunol. 2011;186:5706-18 pubmed publisher |
Kwun H, da Silva S, Qin H, Ferris R, Tan R, Chang Y, et al. The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Virology. 2011;412:357-65 pubmed publisher |
Porgador A, Yewdell J, Deng Y, Bennink J, Germain R. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 1997;6:715-26 pubmed |
